Search
Sorafenib tosylate is used in the treatment of advanced liver cancer. Sorafenib tosylate simultaneously inhibits a variety of kinases present in and on the cell surface, including RAF kinase, vascular endothelial growth factor receptor-2 (VEGFR-2), vascular endothelial growth factor receptor-3 (VEGFR-3), platelet-derived growth factor receptor-β (PDGFR-β), KIT, and FLT-3. It can be seen that sorafenib tosylate has a dual anti-tumor effect, on the one hand, it can directly inhibit tumor growth by inhibiting the RAF/MEK/ERK signaling pathway; On the other hand, it can block the formation of tumor neovascularization by inhibiting VEGFR and PDGFR, and indirectly inhibit the growth of tumor cells.
| Items | Specification |
| Product name | Sorafenib tosylate |
| CAS | 475207-59-1 |
| Appearance | White powder |
| Assay | ≥99% |
| Molecular Formula | C28H24ClF3N4O6S |
| Molecular Weight | 637.0265696 |
| EINECS | 641-758-8 |
| Product parameters | |
| Cas number: | 475207-59-1 |
| Appearance: | White powder |
| Purity: | 99%min |
| Package details: | 1kg/foil bag |
| Brand: | Fortunachem |

Guaranteed purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية